Prof. Hong Yang 杨洪
Chief Physician, Professor
Department of Head and Neck Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of benign and malignant tumors of the thyroid, salivary glands, oral cavity, and pharynx. Focuses on endoscopic-assisted minimally invasive CO2 laser surgery, functional preservation and reconstruction of the larynx and hypopharynx, long-segment tracheal defect repair, and postoperative reconstruction for oral and hypopharyngeal cancers.
Dr. Yang is a Chief Physician, Professor, Department Head, and Master’s supervisor. Dr. Yang was a visiting scholar in head and neck tumor surgery at Laennec Hospital in Paris, France. Dr. Yang is a member of the American Academy of Otolaryngology-Head and Neck Surgery and serves on editorial boards including the Chinese Journal of Otorhinolaryngology-Head and Neck Surgery.
Professional roles
- Vice Chair, Thyroid Cancer Professional Committee, Guangdong Anti-Cancer Association
- Vice Chair, Thyroid Disease Professional Committee, Guangdong Clinical Medical Association
- Chair, Thyroid and Parathyroid Professional Committee, Guangzhou Physician Association
- Vice Chair, Thyroid Disease Professional Committee, Guangzhou Medical Association
Name order: in Chinese the family name comes first (Yang Hong). Papers usually list the name as Hong Yang or Yang H.
Selected publications
14 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cytotechnology, 2025 (senior author): Mechanism of the N6-methyladenosine reader heterogeneous nuclear ribonucleoprotein C facilitating immune escape in thyroid cancer by stabilizing programmed death ligand 1. PubMed 40342628
- J Oncol, 2022 (senior author): Comprehensive Analysis of the Potential Prognostic Value of 11 Glycosylation-Related Genes in Head and Neck Squamous Cell Carcinoma and Their Correlation with PD-L1 Expression and Immune Infiltration. PubMed 35466312
- Med Sci Monit, 2021 (senior author): Retracted: Xanthoxyletin Inhibits Proliferation of Human Oral Squamous Carcinoma Cells and Induces Apoptosis, Autophagy, and Cell Cycle Arrest by Modulation of the MEK/ERK Signaling Pathway. PubMed 33762554
- Med Sci Monit, 2019 (senior author): Xanthoxyletin Inhibits Proliferation of Human Oral Squamous Carcinoma Cells and Induces Apoptosis, Autophagy, and Cell Cycle Arrest by Modulation of the MEK/ERK Signaling Pathway. PubMed 31654522
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion